デフォルト表紙
市場調査レポート
商品コード
1362926

シングルセルゲノムシーケンシングの市場規模、シェア、動向分析:製品タイプ別、疾患領域別、技術別、ワークフロー別、用途別、最終用途別、地域別、セグメント予測、2023年~2030年

Single Cell Genome Sequencing Market Size, Share & Trends Analysis By Product Type (Instruments, Reagents), By Disease Area (Cancer, Immunology), By Technology, By Workflow, By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 185 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
シングルセルゲノムシーケンシングの市場規模、シェア、動向分析:製品タイプ別、疾患領域別、技術別、ワークフロー別、用途別、最終用途別、地域別、セグメント予測、2023年~2030年
出版日: 2023年09月07日
発行: Grand View Research
ページ情報: 英文 185 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

シングルセルゲノムシーケンシング市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界のシングルセルゲノムシーケンシング市場規模は2030年までに75億5,000万米ドルに達すると予測されています。

同市場は2023年から2030年にかけてCAGR 16.1%で成長すると予測されています。がん、糖尿病、関節炎のような慢性疾患の有病率の増加、最新の共同作業と結びついた先進技術、研究開発への投資の増加、老人人口の増加などの要因が、予測期間中の市場成長を促進すると予測されています。

製品のアップグレードに向けた市場参入企業の積極的な参加と貢献は、市場の成長に重要な役割を果たしています。企業間のコラボレーションや戦略的提携の増加が、システムにおける共同ポートフォリオの開発を促進しています。さらに、次世代シークエンシング(NGS)の出現は、過去数年間における市場の大きな牽引力となっています。以前は、シングルセルゲノムシーケンシング市場はPCRとマイクロアレイ技術によって支配されていました。しかし、qPCRとNGSがますます好ましい技術として台頭してきています。

さらに、世界中でシングルセルゲノムシーケンシングセンターや関連施設の数が増加していることが、成長の見通しを促進しています。こうした事業体の主な目的は、シングルセルゲノムシーケンシングに基づく新規アプリケーションや手法を開発することです。これらのセンターはまた、さまざまな地域の科学コミュニティに先進的なツールや機器を導入する上で大きな役割を果たしています。さらに、宇宙関連の政府、非公開会社、研究機関の間の官民協力により、より多くの研究イニシアチブが促進されることが期待されます。NIHやMission Bioのような民間企業による様々な助成金が、市場の成長をエスカレートさせています。

シングルセルゲノムシーケンシング市場レポートハイライト

  • 製品タイプ別では、2022年に機器セグメントが57.43%の収益シェアで市場を独占しました。この優位性は、技術的に先進的な機器の開発および採用が増加したことが主な要因です。
  • 技術別では、PCRが27.77%の収益シェアで2022年の市場を独占しました。研究開発への多額の投資により、PCRはゲノムシーケンシングの分野で広く認知された技術であり、市場のリーダーや研究機関によって高く評価されています。
  • ワークフローに基づくと、ゲノム解析セグメントが2022年の市場を独占し、69.08%の収益シェアを占めました。このセグメントはCAGRが最も早いと予測されています。この優位性は、研究開発能力のための資金調達が最近急増していることと、ゲノム解析製品が広く採用されていることに起因しています。
  • 疾患領域別では、がん分野が2022年の市場シェアを34.95%で独占しました。前立腺がん、大腸がん、乳がんの有病率の増加は、市場成長の有利な機会を生み出すと予測されます。
  • 用途別では、循環腫瘍細胞(CTC)分野が2022年の市場を独占し、28.45%の収益シェアを占めました。これは、がん検出のためのバイオマーカーとしてCTCの臨床応用が拡大しているためです。
  • 地域別では、北米が2022年に46.38%の売上高シェアで市場を独占しました。これは、広範な研究開発活動と、多数の地域プレーヤーの存在によるものです。アジア太平洋地域は、高齢者人口の増加により慢性疾患を患う患者が増加しており、CAGRは17.4%と最も早いと予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • 業界分析ツール
    • ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19感染症の影響分析

第4章 製品タイプのビジネス分析

  • シングルセルゲノムシーケンシング市場:製品タイプの変動分析
  • 機器
  • 試薬

第5章 技術のビジネス分析

  • シングルセルゲノムシーケンシング市場:技術の変動分析
  • NGS
  • PCR
  • qPCR
  • マイクロアレイ
  • MDA

第6章 ワークフローのビジネス分析

  • シングルセルゲノムシーケンシング市場:ワークフローの変動分析
  • ゲノム解析
  • シングルセル単離
  • サンプル調製

第7章 疾患領域のビジネス分析

  • シングルセルゲノムシーケンシング市場:疾患領域の変動分析
  • がん
  • 免疫学
  • 出生前診断
  • 神経生物学
  • 微生物学
  • その他

第8章 用途のビジネス分析

  • シングルセルゲノムシーケンシング市場:用途の変動分析
  • 循環細胞
  • 細胞分化/再プログラミング
  • ゲノム変異
  • 亜集団特性評価
  • その他

第9章 最終用途のビジネス分析

  • シングルセルゲノムシーケンシング市場:最終用途の変動分析
  • 学術・研究機関
  • バイオテクノロジーおよびバイオ医薬品企業
  • クリニック
  • その他

第10章 地域のビジネス分析

  • シングルセルゲノムシーケンシング市場シェア、地域別、2022年および2030年
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第11章 競合情勢

  • 企業の分類
  • 戦略マッピング
  • 企業の市場シェア分析、2022年
  • 企業プロファイル・一覧表
    • Bio-Rad Laboratories
    • 10x Genomics
    • Novogene Co, Ltd
    • Fluidigm
    • BGI
    • Illumina, Inc.
    • Oxford Nanopore Technologies plc.
    • Pacific Biosciences
    • Thermo Fisher Scientific, Inc.
    • QIAGEN
    • F. Hoffmann La-Roche Ltd.
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global Single Cell Genome Sequencing Market, by product type, 2018 - 2030 (USD Million)
  • Table 3 Global Single Cell Genome Sequencing Market, by technology, 2018 - 2030 (USD Million)
  • Table 4 Global Single Cell Genome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
  • Table 5 Global Single Cell Genome Sequencing Market, by disease area, 2018 - 2030 (USD Million)
  • Table 6 Global Single Cell Genome Sequencing Market, by application, 2018 - 2030 (USD Million)
  • Table 7 Global Single Cell Genome Sequencing Market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 Global Single Cell Genome Sequencing Market, by region, 2018 - 2030 (USD Million)
  • Table 9 North America Single Cell Genome Sequencing Market, by country, 2018 - 2030 (USD Million)
  • Table 10 North America Single Cell Genome Sequencing Market, by product type, 2018 - 2030 (USD Million)
  • Table 11 North America Single Cell Genome Sequencing Market, by technology, 2018 - 2030 (USD Million)
  • Table 12 North America Single Cell Genome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
  • Table 13 North America Single Cell Genome Sequencing Market, by disease area, 2018 - 2030 (USD Million)
  • Table 14 North America Single Cell Genome Sequencing Market, by application, 2018 - 2030 (USD Million)
  • Table 15 North America Single Cell Genome Sequencing Market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 U.S. Single Cell Genome Sequencing Market, by product type, 2018 - 2030 (USD Million)
  • Table 17 U.S. Single Cell Genome Sequencing Market, by technology, 2018 - 2030 (USD Million)
  • Table 18 U.S. single cell genome sequencing Market, by workflow, 2018 - 2030 (USD Million)
  • Table 19 U.S. Single Cell Genome Sequencing Market, by disease area, 2018 - 2030 (USD Million)
  • Table 20 U.S. Single Cell Genome Sequencing Market, by application, 2018 - 2030 (USD Million)
  • Table 21 U.S. Single Cell Genome Sequencing Market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Canada Single Cell Genome Sequencing Market, by product type, 2018 - 2030 (USD Million)
  • Table 23 Canada Single Cell Genome Sequencing Market, by technology, 2018 - 2030 (USD Million)
  • Table 24 Canada Single Cell Genome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
  • Table 25 Canada Single Cell Genome Sequencing Market, by disease area, 2018 - 2030 (USD Million)
  • Table 26 Canada Single Cell Genome Sequencing Market, by application, 2018 - 2030 (USD Million)
  • Table 27 Canada Single Cell Genome Sequencing Market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Europe Single Cell Genome Sequencing Market, by country, 2018 - 2030 (USD Million)
  • Table 29 Europe Single Cell Genome Sequencing Market, by product type, 2018 - 2030 (USD Million)
  • Table 30 Europe Single Cell Genome Sequencing Market, by technology, 2018 - 2030 (USD Million)
  • Table 31 Europe Single Cell Genome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
  • Table 32 Europe Single Cell Genome Sequencing Market, by disease area, 2018 - 2030 (USD Million)
  • Table 33 Europe Single Cell Genome Sequencing Market, by application, 2018 - 2030 (USD Million)
  • Table 34 Europe Single Cell Genome Sequencing Market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 UK Single Cell Genome Sequencing Market, by product type, 2018 - 2030 (USD Million)
  • Table 36 UK Single Cell Genome Sequencing Market, by technology, 2018 - 2030 (USD Million)
  • Table 37 UK Single Cell Genome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
  • Table 38 UK Single Cell Genome Sequencing Market, by disease area, 2018 - 2030 (USD Million)
  • Table 39 UK Single Cell Genome Sequencing Market, by application, 2018 - 2030 (USD Million)
  • Table 40 UK Single Cell Genome Sequencing Market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Germany Single Cell Genome Sequencing Market, by product type, 2018 - 2030 (USD Million)
  • Table 42 Germany Single Cell Genome Sequencing Market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Germany Single Cell Genome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
  • Table 44 Germany Single Cell Genome Sequencing Market, by disease area, 2018 - 2030 (USD Million)
  • Table 45 Germany Single Cell Genome Sequencing Market, by application, 2018 - 2030 (USD Million)
  • Table 46 Germany Single Cell Genome Sequencing Market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 France Single Cell Genome Sequencing Market, by product type, 2018 - 2030 (USD Million)
  • Table 48 France Single Cell Genome Sequencing Market, by technology, 2018 - 2030 (USD Million)
  • Table 49 France Single Cell Genome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
  • Table 50 France Single Cell Genome Sequencing Market, by disease area, 2018 - 2030 (USD Million)
  • Table 51 France Single Cell Genome Sequencing Market, by application, 2018 - 2030 (USD Million)
  • Table 52 France Single Cell Genome Sequencing Market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Italy Single Cell Genome Sequencing Market, by product type, 2018 - 2030 (USD Million)
  • Table 54 Italy Single Cell Genome Sequencing Market, by technology, 2018 - 2030 (USD Million)
  • Table 55 Italy Single Cell Genome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
  • Table 56 Italy Single Cell Genome Sequencing Market, by disease area, 2018 - 2030 (USD Million)
  • Table 57 Italy Single Cell Genome Sequencing Market, by application, 2018 - 2030 (USD Million)
  • Table 58 Italy Single Cell Genome Sequencing Market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Spain Single Cell Genome Sequencing Market, by product type, 2018 - 2030 (USD Million)
  • Table 60 Spain Single Cell Genome Sequencing Market, by technology, 2018 - 2030 (USD Million)
  • Table 61 Spain Single Cell Genome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
  • Table 62 Spain Single Cell Genome Sequencing Market, by disease area, 2018 - 2030 (USD Million)
  • Table 63 Spain Single Cell Genome Sequencing Market, by application, 2018 - 2030 (USD Million)
  • Table 64 Spain Single Cell Genome Sequencing Market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 Denmark Single Cell Genome Sequencing Market, by product type, 2018 - 2030 (USD Million)
  • Table 66 Denmark Single Cell Genome Sequencing Market, by technology, 2018 - 2030 (USD Million)
  • Table 67 Denmark Single Cell Genome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
  • Table 68 Denmark Single Cell Genome Sequencing Market, by disease area, 2018 - 2030 (USD Million)
  • Table 69 Denmark Single Cell Genome Sequencing Market, by application, 2018 - 2030 (USD Million)
  • Table 70 Denmark Single Cell Genome Sequencing Market, by end-use, 2018 - 2030 (USD Million)
  • Table 71 Sweden Single Cell Genome Sequencing Market, by product type, 2018 - 2030 (USD Million)
  • Table 72 Sweden Single Cell Genome Sequencing Market, by technology, 2018 - 2030 (USD Million)
  • Table 73 Sweden Single Cell Genome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
  • Table 74 Sweden Single Cell Genome Sequencing Market, by disease area, 2018 - 2030 (USD Million)
  • Table 75 Sweden Single Cell Genome Sequencing Market, by application, 2018 - 2030 (USD Million)
  • Table 76 Sweden Single Cell Genome Sequencing Market, by end-use, 2018 - 2030 (USD Million)
  • Table 77 Norway Single Cell Genome Sequencing Market, by product type, 2018 - 2030 (USD Million)
  • Table 78 Norway Single Cell Genome Sequencing Market, by technology, 2018 - 2030 (USD Million)
  • Table 79 Norway Single Cell Genome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
  • Table 80 Norway Single Cell Genome Sequencing Market, by disease area, 2018 - 2030 (USD Million)
  • Table 81 Norway Single Cell Genome Sequencing Market, by application, 2018 - 2030 (USD Million)
  • Table 82 Norway Single Cell Genome Sequencing Market, by end-use, 2018 - 2030 (USD Million)
  • Table 83 Asia Pacific Single Cell Genome Sequencing Market, by country, 2018 - 2030 (USD Million)
  • Table 84 Asia Pacific Single Cell Genome Sequencing Market, by product type, 2018 - 2030 (USD Million)
  • Table 85 Asia Pacific Single Cell Genome Sequencing Market, by technology, 2018 - 2030 (USD Million)
  • Table 86 Asia Pacific Single Cell Genome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
  • Table 87 Asia Pacific Single Cell Genome Sequencing Market, by disease area, 2018 - 2030 (USD Million)
  • Table 88 Asia Pacific Single Cell Genome Sequencing Market, by application, 2018 - 2030 (USD Million)
  • Table 89 Asia Pacific Single Cell Genome Sequencing Market, by end-use, 2018 - 2030 (USD Million)
  • Table 90 Japan Single Cell Genome Sequencing Market, by product type, 2018 - 2030 (USD Million)
  • Table 91 Japan Single Cell Genome Sequencing Market, by technology, 2018 - 2030 (USD Million)
  • Table 92 Japan Single Cell Genome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
  • Table 93 Japan Single Cell Genome Sequencing Market, by disease area, 2018 - 2030 (USD Million)
  • Table 94 Japan Single Cell Genome Sequencing Market, by application, 2018 - 2030 (USD Million)
  • Table 95 Japan Single Cell Genome Sequencing Market, by end-use, 2018 - 2030 (USD Million)
  • Table 96 China Single Cell Genome Sequencing Market, by product type, 2018 - 2030 (USD Million)
  • Table 97 China Single Cell Genome Sequencing Market, by technology, 2018 - 2030 (USD Million)
  • Table 98 China Single Cell Genome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
  • Table 99 China Single Cell Genome Sequencing Market, by disease area, 2018 - 2030 (USD Million)
  • Table 100 China Single Cell Genome Sequencing Market, by application, 2018 - 2030 (USD Million)
  • Table 101 China Single Cell Genome Sequencing Market, by end-use, 2018 - 2030 (USD Million)
  • Table 102 India Single Cell Genome Sequencing Market, by product type, 2018 - 2030 (USD Million)
  • Table 103 India Single Cell Genome Sequencing Market, by technology, 2018 - 2030 (USD Million)
  • Table 104 India Single Cell Genome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
  • Table 105 India Single Cell Genome Sequencing Market, by disease area, 2018 - 2030 (USD Million)
  • Table 106 India Single Cell Genome Sequencing Market, by application, 2018 - 2030 (USD Million)
  • Table 107 India Single Cell Genome Sequencing Market, by end-use, 2018 - 2030 (USD Million)
  • Table 108 Australia Single Cell Genome Sequencing Market, by product type, 2018 - 2030 (USD Million)
  • Table 109 Australia Single Cell Genome Sequencing Market, by technology, 2018 - 2030 (USD Million)
  • Table 110 Australia Single Cell Genome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
  • Table 111 Australia Single Cell Genome Sequencing Market, by disease area, 2018 - 2030 (USD Million)
  • Table 112 Australia Single Cell Genome Sequencing Market, by application, 2018 - 2030 (USD Million)
  • Table 113 Australia Single Cell Genome Sequencing Market, by end-use, 2018 - 2030 (USD Million)
  • Table 114 Thailand Single Cell Genome Sequencing Market, by product type, 2018 - 2030 (USD Million)
  • Table 115 Thailand Single Cell Genome Sequencing Market, by technology, 2018 - 2030 (USD Million)
  • Table 116 Thailand Single Cell Genome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
  • Table 117 Thailand Single Cell Genome Sequencing Market, by disease area, 2018 - 2030 (USD Million)
  • Table 118 Thailand Single Cell Genome Sequencing Market, by application, 2018 - 2030 (USD Million)
  • Table 119 Thailand Single Cell Genome Sequencing Market, by end-use, 2018 - 2030 (USD Million)
  • Table 120 South Korea Single Cell Genome Sequencing Market, by product type, 2018 - 2030 (USD Million)
  • Table 121 South Korea Single Cell Genome Sequencing Market, by technology, 2018 - 2030 (USD Million)
  • Table 122 South Korea Single Cell Genome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
  • Table 123 South Korea Single Cell Genome Sequencing Market, by disease area, 2018 - 2030 (USD Million)
  • Table 124 South Korea Single Cell Genome Sequencing Market, by application, 2018 - 2030 (USD Million)
  • Table 125 South Korea Single Cell Genome Sequencing Market, by end-use, 2018 - 2030 (USD Million)
  • Table 126 Latin America Single Cell Genome Sequencing Market, by country, 2018 - 2030 (USD Million)
  • Table 127 Latin America Single Cell Genome Sequencing Market, by product type, 2018 - 2030 (USD Million)
  • Table 128 Latin America Single Cell Genome Sequencing Market, by technology, 2018 - 2030 (USD Million)
  • Table 129 Latin America Single Cell Genome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
  • Table 130 Latin America Single Cell Genome Sequencing Market, by disease area, 2018 - 2030 (USD Million)
  • Table 131 Latin America Single Cell Genome Sequencing Market, by application, 2018 - 2030 (USD Million)
  • Table 132 Latin America Single Cell Genome Sequencing Market, by end-use, 2018 - 2030 (USD Million)
  • Table 133 Brazil Single Cell Genome Sequencing Market, by product type, 2018 - 2030 (USD Million)
  • Table 134 Brazil Single Cell Genome Sequencing Market, by technology, 2018 - 2030 (USD Million)
  • Table 135 Brazil Single Cell Genome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
  • Table 136 Brazil Single Cell Genome Sequencing Market, by disease area, 2018 - 2030 (USD Million)
  • Table 137 Brazil Single Cell Genome Sequencing Market, by application, 2018 - 2030 (USD Million)
  • Table 138 Brazil Single Cell Genome Sequencing Market, by end-use, 2018 - 2030 (USD Million)
  • Table 139 Mexico Single Cell Genome Sequencing Market, by product type, 2018 - 2030 (USD Million)
  • Table 140 Mexico Single Cell Genome Sequencing Market, by technology, 2018 - 2030 (USD Million)
  • Table 141 Mexico Single Cell Genome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
  • Table 142 Mexico Single Cell Genome Sequencing Market, by disease area, 2018 - 2030 (USD Million)
  • Table 143 Mexico Single Cell Genome Sequencing Market, by application, 2018 - 2030 (USD Million)
  • Table 144 Mexico Single Cell Genome Sequencing Market, by end-use, 2018 - 2030 (USD Million)
  • Table 145 Argentina Single Cell Genome Sequencing Market, by product type, 2018 - 2030 (USD Million)
  • Table 146 Argentina Single Cell Genome Sequencing Market, by technology, 2018 - 2030 (USD Million)
  • Table 147 Argentina Single Cell Genome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
  • Table 148 Argentina Single Cell Genome Sequencing Market, by disease area, 2018 - 2030 (USD Million)
  • Table 149 Argentina Single Cell Genome Sequencing Market, by application, 2018 - 2030 (USD Million)
  • Table 150 Argentina Single Cell Genome Sequencing Market, by end-use, 2018 - 2030 (USD Million)
  • Table 151 MEA Single Cell Genome Sequencing Market, by country, 2018 - 2030 (USD Million)
  • Table 152 MEA Single Cell Genome Sequencing Market, by product type, 2018 - 2030 (USD Million)
  • Table 153 MEA Single Cell Genome Sequencing Market, by technology, 2018 - 2030 (USD Million)
  • Table 154 MEA Single Cell Genome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
  • Table 155 MEA cell genome sequencing market, by disease area, 2018 - 2030 (USD Million)
  • Table 156 MEA Single Cell Genome Sequencing Market, by application, 2018 - 2030 (USD Million)
  • Table 157 MEA Single Cell Genome Sequencing Market, by end-use, 2018 - 2030 (USD Million)
  • Table 158 South Africa Single Cell Genome Sequencing Market, by product type, 2018 - 2030 (USD Million)
  • Table 159 South Africa Single Cell Genome Sequencing Market, by technology, 2018 - 2030 (USD Million)
  • Table 160 South Africa Single Cell Genome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
  • Table 161 South Africa Single Cell Genome Sequencing Market, by disease area, 2018 - 2030 (USD Million)
  • Table 162 South Africa Single Cell Genome Sequencing Market, by application, 2018 - 2030 (USD Million)
  • Table 163 South Africa Single Cell Genome Sequencing Market, by end-use, 2018 - 2030 (USD Million)
  • Table 164 Saudi Arabia Single Cell Genome Sequencing Market, by product type, 2018 - 2030 (USD Million)
  • Table 165 Saudi Arabia Single Cell Genome Sequencing Market, by technology, 2018 - 2030 (USD Million)
  • Table 166 Saudi Arabia Single Cell Genome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
  • Table 167 Saudi Arabia Single Cell Genome Sequencing Market, by disease area, 2018 - 2030 (USD Million)
  • Table 168 Saudi Arabia Single Cell Genome Sequencing Market, by application, 2018 - 2030 (USD Million)
  • Table 169 Saudi Arabia Single Cell Genome Sequencing Market, by end-use, 2018 - 2030 (USD Million)
  • Table 170 UAE Single Cell Genome Sequencing Market, by product type, 2018 - 2030 (USD Million)
  • Table 171 UAE Single Cell Genome Sequencing Market, by technology, 2018 - 2030 (USD Million)
  • Table 172 UAE Single Cell Genome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
  • Table 173 UAE Single Cell Genome Sequencing Market, by disease area, 2018 - 2030 (USD Million)
  • Table 174 UAE Single Cell Genome Sequencing Market, by application, 2018 - 2030 (USD Million)
  • Table 175 UAE Single Cell Genome Sequencing Market, by end-use, 2018 - 2030 (USD Million)
  • Table 176 Kuwait Single Cell Genome Sequencing Market, by product type, 2018 - 2030 (USD Million)
  • Table 177 Kuwait Single Cell Genome Sequencing Market, by technology, 2018 - 2030 (USD Million)
  • Table 178 Kuwait Single Cell Genome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
  • Table 179 Kuwait Single Cell Genome Sequencing Market, by disease area, 2018 - 2030 (USD Million)
  • Table 180 Kuwait Single Cell Genome Sequencing Market, by application, 2018 - 2030 (USD Million)
  • Table 181 Kuwait Single Cell Genome Sequencing Market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 single cell genome sequencing market segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 PESTEL analysis
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Global single cell genome sequencing market: Product Type movement analysis
  • Fig. 15 Global Single Cell Genome Sequencing Market, for instruments, 2018 - 2030 (USD Million)
  • Fig. 16 Global Single Cell Genome Sequencing Market, for reagents, 2018 - 2030 (USD Million)
  • Fig. 17 Global single cell genome sequencing market: Technology movement analysis
  • Fig. 18 Global Single Cell Genome Sequencing Market, for NGS, 2018 - 2030 (USD Million)
  • Fig. 19 Global Single Cell Genome Sequencing Market, for PCR, 2018 - 2030 (USD Million)
  • Fig. 20 Global Single Cell Genome Sequencing Market, for qPCR, 2018 - 2030 (USD Million)
  • Fig. 21 Global Single Cell Genome Sequencing Market, for microarray, 2018 - 2030 (USD Million)
  • Fig. 22 Global Single Cell Genome Sequencing Market, for MDA, 2018 - 2030 (USD Million)
  • Fig. 23 Global single cell genome sequencing market: Workflow movement analysis
  • Fig. 24 Global Single Cell Genome Sequencing Market, for genomic analysis, 2018 - 2030 (USD Million)
  • Fig. 25 Global Single Cell Genome Sequencing Market, for single cell isolation, 2018 - 2030 (USD Million)
  • Fig. 26 Global Single Cell Genome Sequencing Market, for sample preparation, 2018 - 2030 (USD Million)
  • Fig. 27 Global single cell genome sequencing market: Disease Area movement analysis
  • Fig. 28 Global Single Cell Genome Sequencing Market, for cancer, 2018 - 2030 (USD Million)
  • Fig. 29 Global Single Cell Genome Sequencing Market, for immunology, 2018 - 2030 (USD Million)
  • Fig. 30 Global Single Cell Genome Sequencing Market, for prenatal diagnosis, 2018 - 2030 (USD Million)
  • Fig. 31 Global Single Cell Genome Sequencing Market, for neurobiology, 2018 - 2030 (USD Million)
  • Fig. 32 Global Single Cell Genome Sequencing Market, for microbiology, 2018 - 2030 (USD Million)
  • Fig. 33 Global Single Cell Genome Sequencing Market, for other disaster areas, 2018 - 2030 (USD Million)
  • Fig. 34 Global single cell genome sequencing market: Application movement analysis
  • Fig. 35 Global Single Cell Genome Sequencing Market, for circulating cells, 2018 - 2030 (USD Million)
  • Fig. 36 Global Single Cell Genome Sequencing Market, for cell differentiation/reprogramming, 2018 - 2030 (USD Million)
  • Fig. 37 Global Single Cell Genome Sequencing Market, for genomic variation, 2018 - 2030 (USD Million)
  • Fig. 38 Global Single Cell Genome Sequencing Market, for subpopulation characterization, 2018 - 2030 (USD Million)
  • Fig. 39 Global Single Cell Genome Sequencing Market, for other applications, 2018 - 2030 (USD Million)
  • Fig. 40 Global single cell genome sequencing market: End-use movement analysis
  • Fig. 41 Global Single Cell Genome Sequencing Market, for academic & research laboratories, 2018 - 2030 (USD Million)
  • Fig. 42 Global Single Cell Genome Sequencing Market, for biotechnology & biopharmaceutical companies, 2018 - 2030 (USD Million)
  • Fig. 43 Global Single Cell Genome Sequencing Market, for clinics, 2018 - 2030 (USD Million)
  • Fig. 44 Global Single Cell Genome Sequencing Market, for other end-use, 2018 - 2030 (USD Million)
  • Fig. 45 Regional marketplace: Key takeaways
  • Fig. 46 Regional outlook, 2022 & 2030
  • Fig. 47 Global single cell genome sequencing market: Region movement analysis
  • Fig. 48 North America Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 49 U.S. Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 50 Canada Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 51 Europe Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 52 Germany Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 53 UK Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 54 France Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 55 Italy Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 56 Spain Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 57 Denmark Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 58 Sweden Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 59 Norway Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 60 Asia Pacific Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 61 Japan Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 62 China Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 63 India Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 64 Australia Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 65 South Korea Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 66 Thailand Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 67 Latin America Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 68 Brazil Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 69 Mexico Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 70 Argentina Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 71 Middle East and Africa Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 72 South Africa Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 73 Saudi Arabia Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 74 UAE Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 75 Kuwait Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-2-68038-352-2

Single Cell Genome Sequencing Market Growth & Trends:

The global single cell genome sequencing market size is anticipated to reach USD 7.55 billion by 2030, according to a new report by Grand View Research, Inc.. The market is projected to grow at a CAGR of 16.1% from 2023 to 2030. Factor such as the increasing prevalence of chronic diseases like cancer, diabetes, and arthritis; advanced technology coupled with the latest collaborative efforts; increased investments in R&D; and rising geriatric population are anticipated to drive the market growth over the forecast period.

Active participation and contribution of market players toward product upgradation play an important role in the growth of the market. Increasing number of collaborations and strategic alliances between companies are fostering the development of a collaborative portfolio in the system. Moreover, the emergence of next-generation sequencing (NGS) has helped the market gain tremendous traction over the past few years. Earlier, single-cell genome sequencing market was dominated by PCR and microarray technologies. However, qPCR and NGS are increasingly emerging as the preferred technologies.

Furthermore, the rising number of single-cell genome sequencing centers & associated facilities worldwide is fostering growth prospects. The main objective of such entities is to develop novel single-cell genome sequencing-based applications and methods. These centers are also playing a major role in introducing advanced tools & instruments for scientific communities of various regions. In addition, public-private collaborations among governments, companies, and research institutions related to space are expected to promote more research initiatives. Various funding grants by NIH and private players such as Mission Bio are escalating the growth of the market.

Single Cell Genome Sequencing Market Report Highlights:

  • Based on product type, the instruments segment dominated the market in 2022, with a revenue share of 57.43%. This domination can be largely attributed to the increased development and adoption of technologically advanced instruments
  • Based on technology, PCR dominated the market in 2022, with a revenue share of 27.77%. Due to heavy investments in R&D, PCR is a widely recognized technology in the field of genome sequencing, highly coveted by market leaders and research institutes
  • Based on workflow, the genomic analysis segment dominated the market in 2022, with a revenue share of 69.08%. This segment is also forecasted to have the fastest CAGR. This dominance can be attributed to the recent surge in funding for research and development capabilities and the widespread adoption of genomic analysis products
  • Based on disease area, the cancer segment dominated the market in 2022 with a market share of 34.95%. The increasing prevalence of prostate, colorectal, and breast cancer is projected to generate lucrative opportunities for market growth.
  • Based on application, the circulating tumor cells (CTCs) segment dominated the market in 2022, with a revenue share of 28.45%. This is due to the growing clinical application of CTCs as biomarkers for cancer detection
  • Based on region, North America dominated the market in 2022 with a revenue share of 46.38%. owing to the extensive research and development activities, and the presence of a significant number of regional players. Asia Pacific region is anticipated to witness the fastest CAGR of 17.4% due to the rising geriatric population, leading to an increase in patients suffering from chronic diseases

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment definitions
      • 1.1.1.1. Product segment
      • 1.1.1.2. Workflow segment
      • 1.1.1.3. Application segment
      • 1.1.1.4. Technology segment
      • 1.1.1.5. Disease Area segment
      • 1.1.1.6. End-use segment
    • 1.1.2. Regional Scope
    • 1.1.3. Estimates and forecast time.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information Or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market formulation and validation
  • 1.6. Objectives
    • 1.6.1. Objective 1
    • 1.6.2. Objective 2
    • 1.6.3. Objective 3

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Product Launches by Market Players
      • 3.2.1.2. Increasing Prevalence of Cancer
      • 3.2.1.3. High R&D in the Single Cell Genomics Space
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Costs of Genome Sequencing Instruments
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Type Business Analysis

  • 4.1. Single Cell Genome Sequencing Market: Product Type Movement Analysis
  • 4.2. Instruments
    • 4.2.1. Instruments Market, 2018 - 2030 (USD Million)
  • 4.3. Reagents
    • 4.3.1. Reagents Market, 2018 - 2030 (USD Million)

Chapter 5. Technology Business Analysis

  • 5.1. Single Cell Genome Sequencing Market: Technology Movement Analysis
  • 5.2. NGS
    • 5.2.1. NGS Market, 2018 - 2030 (USD Million)
  • 5.3. PCR
    • 5.3.1. PCR Market, 2018 - 2030 (USD Million)
  • 5.4. qPCR
    • 5.4.1. qPCR Market, 2018 - 2030 (USD Million)
  • 5.5. Microarray
    • 5.5.1. Microarray Market, 2018 - 2030 (USD Million)
  • 5.6. MDA
    • 5.6.1. MDA Market, 2018 - 2030 (USD Million)

Chapter 6. Workflow Business Analysis

  • 6.1. Single Cell Genome Sequencing Market: Workflow Movement Analysis
  • 6.2. Genomic Analysis
    • 6.2.1. Genomic Analysis Market, 2018 - 2030 (USD Million)
  • 6.3. Single Cell Isolation
    • 6.3.1. Single Cell Isolation Market, 2018 - 2030 (USD Million)
  • 6.4. Sample Preparation
    • 6.4.1. Sample Preparation Market, 2018 - 2030 (USD Million)

Chapter 7. Disease Area Business Analysis

  • 7.1. Single Cell Genome Sequencing Market: Disease Area Movement Analysis
  • 7.2. Cancer
    • 7.2.1. Cancer Market, 2018 - 2030 (USD Million)
  • 7.3. Immunology
    • 7.3.1. Immunology Market, 2018 - 2030 (USD Million)
  • 7.4. Prenatal Diagnosis
    • 7.4.1. Prenatal Diagnosis Market, 2018 - 2030 (USD Million)
  • 7.5. Neurobiology
    • 7.5.1. Neurobiology Market, 2018 - 2030 (USD Million)
  • 7.6. Microbiology
    • 7.6.1. Microbiology Market, 2018 - 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Other Disease Areas Market, 2018 - 2030 (USD Million)

Chapter 8. Application Business Analysis

  • 8.1. Single Cell Genome Sequencing Market: Application Movement Analysis
  • 8.2. Circulating Cells
    • 8.2.1. Circulating Cells Market, 2018 - 2030 (USD Million)
  • 8.3. Cell Differentiation/Reprogramming
    • 8.3.1. Cell Differentiation/Reprogramming Market, 2018 - 2030 (USD Million)
  • 8.4. Genomic Variation
    • 8.4.1. Genomic Variation Market, 2018 - 2030 (USD Million)
  • 8.5. Subpopulation Characterization
    • 8.5.1. Subpopulation Characterization Market, 2018 - 2030 (USD Million)
  • 8.6. Others
    • 8.6.1. Other Applications Market, 2018 - 2030 (USD Million)

Chapter 9. End-use Business Analysis

  • 9.1. Single Cell Genome Sequencing Market: End-use Movement Analysis
  • 9.2. Academic & Research Laboratories
    • 9.2.1. Academic & Research Laboratories Market, 2018 - 2030 (USD Million)
  • 9.3. Biotechnology & Biopharmaceutical Companies
    • 9.3.1. Biotechnology & Biopharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • 9.4. Clinics
    • 9.4.1. Clinics Market, 2018 - 2030 (USD Million)
  • 9.5. Others
    • 9.5.1. Other End-uses Market, 2018 - 2030 (USD Million)

Chapter 10. Regional Business Analysis

  • 10.1. Single Cell Genome Sequencing Market Share, By Region, 2022 & 2030
  • 10.2. North America
    • 10.2.1. SWOT Analysis
    • 10.2.2. North America Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 10.2.3. U.S.
      • 10.2.3.1. Key Country Dynamics
      • 10.2.3.2. Target Disease Prevalence
      • 10.2.3.3. Competitive Scenario
      • 10.2.3.4. Regulatory Framework
      • 10.2.3.5. U.S. Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 10.2.4. Canada
      • 10.2.4.1. Key Country Dynamics
      • 10.2.4.2. Target Disease Prevalence
      • 10.2.4.3. Competitive Scenario
      • 10.2.4.4. Regulatory Framework
      • 10.2.4.5. Canada Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 10.3. Europe
    • 10.3.1. SWOT Analysis
    • 10.3.2. Europe Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 10.3.3. UK
      • 10.3.3.1. Key Country Dynamics
      • 10.3.3.2. Target Disease Prevalence
      • 10.3.3.3. Competitive Scenario
      • 10.3.3.4. Regulatory Framework
      • 10.3.3.5. UK Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 10.3.4. Germany
      • 10.3.4.1. Key Country Dynamics
      • 10.3.4.2. Target Disease Prevalence
      • 10.3.4.3. Competitive Scenario
      • 10.3.4.4. Regulatory Framework
      • 10.3.4.5. Germany Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 10.3.5. France
      • 10.3.5.1. Key Country Dynamics
      • 10.3.5.2. Target Disease Prevalence
      • 10.3.5.3. Competitive Scenario
      • 10.3.5.4. Regulatory Framework
      • 10.3.5.5. France Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 10.3.6. Italy
      • 10.3.6.1. Key Country Dynamics
      • 10.3.6.2. Target Disease Prevalence
      • 10.3.6.3. Competitive Scenario
      • 10.3.6.4. Regulatory Framework
      • 10.3.6.5. Italy Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 10.3.7. Spain
      • 10.3.7.1. Key Country Dynamics
      • 10.3.7.2. Target Disease Prevalence
      • 10.3.7.3. Competitive Scenario
      • 10.3.7.4. Regulatory Framework
      • 10.3.7.5. Spain Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 10.3.8. Denmark
      • 10.3.8.1. Key Country Dynamics
      • 10.3.8.2. Target Disease Prevalence
      • 10.3.8.3. Competitive Scenario
      • 10.3.8.4. Regulatory Framework
      • 10.3.8.5. Denmark Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 10.3.9. Sweden
      • 10.3.9.1. Key Country Dynamics
      • 10.3.9.2. Target Disease Prevalence
      • 10.3.9.3. Competitive Scenario
      • 10.3.9.4. Regulatory Framework
      • 10.3.9.5. Sweden Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 10.3.10. Norway
      • 10.3.10.1. Key Country Dynamics
      • 10.3.10.2. Target Disease Prevalence
      • 10.3.10.3. Competitive Scenario
      • 10.3.10.4. Regulatory Framework
      • 10.3.10.5. Norway Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 10.4. Asia Pacific
    • 10.4.1. SWOT Analysis
    • 10.4.2. Asia Pacific Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 10.4.3. Japan
      • 10.4.3.1. Key Country Dynamics
      • 10.4.3.2. Target Disease Prevalence
      • 10.4.3.3. Competitive Scenario
      • 10.4.3.4. Regulatory Framework
      • 10.4.3.5. Japan Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 10.4.4. China
      • 10.4.4.1. Key Country Dynamics
      • 10.4.4.2. Target Disease Prevalence
      • 10.4.4.3. Competitive Scenario
      • 10.4.4.4. Regulatory Framework
      • 10.4.4.5. China Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 10.4.5. India
      • 10.4.5.1. Key Country Dynamics
      • 10.4.5.2. Target Disease Prevalence
      • 10.4.5.3. Competitive Scenario
      • 10.4.5.4. Regulatory Framework
      • 10.4.5.5. India Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 10.4.6. Australia
      • 10.4.6.1. Key Country Dynamics
      • 10.4.6.2. Target Disease Prevalence
      • 10.4.6.3. Competitive Scenario
      • 10.4.6.4. Regulatory Framework
      • 10.4.6.5. Australia Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 10.4.7. Thailand
      • 10.4.7.1. Key Country Dynamics
      • 10.4.7.2. Target Disease Prevalence
      • 10.4.7.3. Competitive Scenario
      • 10.4.7.4. Regulatory Framework
      • 10.4.7.5. Thailand Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 10.4.8. South Korea
      • 10.4.8.1. Key Country Dynamics
      • 10.4.8.2. Target Disease Prevalence
      • 10.4.8.3. Competitive Scenario
      • 10.4.8.4. Regulatory Framework
      • 10.4.8.5. South Korea Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 10.5. Latin America
    • 10.5.1. SWOT Analysis
    • 10.5.2. Latin America Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 10.5.3. Brazil
      • 10.5.3.1. Key Country Dynamics
      • 10.5.3.2. Target Disease Prevalence
      • 10.5.3.3. Competitive Scenario
      • 10.5.3.4. Regulatory Framework
      • 10.5.3.5. Brazil Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 10.5.4. Mexico
      • 10.5.4.1. Key Country Dynamics
      • 10.5.4.2. Target Disease Prevalence
      • 10.5.4.3. Competitive Scenario
      • 10.5.4.4. Regulatory Framework
      • 10.5.4.5. Mexico Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 10.5.5. Argentina
      • 10.5.5.1. Key Country Dynamics
      • 10.5.5.2. Target Disease Prevalence
      • 10.5.5.3. Competitive Scenario
      • 10.5.5.4. Regulatory Framework
      • 10.5.5.5. Argentina Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
  • 10.6. MEA
    • 10.6.1. SWOT Analysis
    • 10.6.2. MEA Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 10.6.3. South Africa
      • 10.6.3.1. Key Country Dynamics
      • 10.6.3.2. Target Disease Prevalence
      • 10.6.3.3. Competitive Scenario
      • 10.6.3.4. Regulatory Framework
      • 10.6.3.5. South Africa Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 10.6.4. Saudi Arabia
      • 10.6.4.1. Key Country Dynamics
      • 10.6.4.2. Target Disease Prevalence
      • 10.6.4.3. Competitive Scenario
      • 10.6.4.4. Regulatory Framework
      • 10.6.4.5. Saudi Arabia Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 10.6.5. UAE
      • 10.6.5.1. Key Country Dynamics
      • 10.6.5.2. Target Disease Prevalence
      • 10.6.5.3. Competitive Scenario
      • 10.6.5.4. Regulatory Framework
      • 10.6.5.5. UAE Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)
    • 10.6.6. Kuwait
      • 10.6.6.1. Key Country Dynamics
      • 10.6.6.2. Target Disease Prevalence
      • 10.6.6.3. Competitive Scenario
      • 10.6.6.4. Regulatory Framework
      • 10.6.6.5. Kuwait Single Cell Genome Sequencing Market, 2018 - 2030 (USD Million)

Chapter 11. Competitive Landscape

  • 11.1. Company Categorization
  • 11.2. Strategy Mapping
  • 11.3. Company Market Share Analysis, 2022
  • 11.4. Company Profiles/Listing
    • 11.4.1. Bio-Rad Laboratories
      • 11.4.1.1. Overview
      • 11.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.1.3. Product Benchmarking
      • 11.4.1.4. Strategic Initiatives
    • 11.4.2. 10x Genomics
      • 11.4.2.1. Overview
      • 11.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.2.3. Product Benchmarking
      • 11.4.2.4. Strategic Initiatives
    • 11.4.3. Novogene Co, Ltd
      • 11.4.3.1. Overview
      • 11.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.3.3. Product Benchmarking
      • 11.4.3.4. Strategic Initiatives
    • 11.4.4. Fluidigm
      • 11.4.4.1. Overview
      • 11.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.4.3. Product Benchmarking
      • 11.4.4.4. Strategic Initiatives
    • 11.4.5. BGI
      • 11.4.5.1. Overview
      • 11.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.5.3. Product Benchmarking
      • 11.4.5.4. Strategic Initiatives
    • 11.4.6. Illumina, Inc.
      • 11.4.6.1. Overview
      • 11.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.6.3. Product Benchmarking
      • 11.4.6.4. Strategic Initiatives
    • 11.4.7. Oxford Nanopore Technologies plc.
      • 11.4.7.1. Overview
      • 11.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.7.3. Product Benchmarking
      • 11.4.7.4. Strategic Initiatives
    • 11.4.8. Pacific Biosciences
      • 11.4.8.1. Overview
      • 11.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.8.3. Product Benchmarking
      • 11.4.8.4. Strategic Initiatives
    • 11.4.9. Thermo Fisher Scientific, Inc.
      • 11.4.9.1. Overview
      • 11.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.9.3. Product Benchmarking
      • 11.4.9.4. Strategic Initiatives
    • 11.4.10. QIAGEN
      • 11.4.10.1. Overview
      • 11.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.10.3. Product Benchmarking
      • 11.4.10.4. Strategic Initiatives
    • 11.4.11. F. Hoffmann La-Roche Ltd.
      • 11.4.11.1. Overview
      • 11.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 11.4.11.3. Product Benchmarking
      • 11.4.11.4. Strategic Initiatives